Spec analysis — not yet tested
What this page is. A podiatrist’s reading of the manufacturer’s published specifications for the New Balance 928v3. Nothing on this page has been measured, worn or scored by us yet. There is no score and no seal here on purpose: under our standard, a number only appears once a pair has been on the bench and on the road. When this shoe is tested, this page is replaced by the full review and the change is logged.
The 928 is the white leather walking shoe that half the waiting room is wearing, and it has stayed at v3 for a long time while everything around it got a new version every eighteen months. That is not neglect — it is a shoe built for a job that has not changed: walk a lot, on hard floors, on a foot that rolls in, with room for a device. It is also the shoe people panic about, because a stable model that never updates looks discontinued from the outside. It is not. Below is what New Balance publishes about it and what a spec sheet can and cannot tell you.
What New Balance says the 928v3 is
New Balance describes the 928v3 as a motion-control walking shoe. Its listing names three things: ROLLBAR, which the brand says “reinforces the medial and lateral sides of the midsole, reducing rear-foot movement and promoting a stable, controlled walking gait”; ABZORB cushioning, which it describes as absorbing impact “at the heel and forefoot”; and a premium leather upper for structured support that “holds up through daily wear”.
It is sold in the walking category rather than the running category, and it was listed at $159.99 and in stock on newbalance.com when this page was written. Whatever else is true of the 928, it is not discontinued.
Manufacturer specifications
Source column tells you where each figure comes from. “New Balance” means the brand’s own US product page. A retailer name means the brand does not publish that figure and a retailer does. “Not published” means nobody reliable does — those are the figures our bench measures first.
| Specification | Figure | Source |
|---|---|---|
| Category | Motion control, walking | New Balance |
| Support device | ROLLBAR — reinforces medial and lateral midsole to reduce rear-foot movement | New Balance |
| Cushioning | ABZORB at heel and forefoot | New Balance |
| Upper | Premium leather | New Balance |
| Closure | Lace-up (a strap version is sold separately) | New Balance |
| List price | $159.99, listed in stock on newbalance.com, 9 September 2026 | New Balance |
| Heel-to-toe drop | Not published | — |
| Weight | Not published for the shoe (Amazon lists a 1.1 lb shipping weight, which is packaging, not the shoe) | — |
| Stack heights | Not published | — |
| Internal toe-box width and depth | Not published | — |
| Removable insole / orthotic volume | Not published | — |
Figures checked September 9, 2026. Source: New Balance’s own product listing for the 928v3, read 9 September 2026 via its US retail listings; newbalance.com blocks automated access, so price and stock were confirmed from New Balance’s own indexed product data on the same date.
What the spec sheet suggests — and what only a test can answer
This is a shoe designed around hours, not miles. Everything New Balance names — leather that holds its shape, a rearfoot post, cushioning placed at heel and forefoot rather than spread evenly — points at the same user: someone upright on a hard floor for a long shift, or someone walking daily for cardiovascular reasons rather than for sport. Nurses, teachers, warehouse staff, retirees under instruction to walk thirty minutes a day. Reading the spec sheet as a running shoe’s will mislead you.
Leather is a real clinical variable and it cuts both ways. A structured leather upper resists the slow collapse that lets a foot slide medially inside a soft mesh shoe, which is the point. But leather does not stretch to accommodate a bunion, a hammertoe or a dorsal exostosis the way engineered mesh does — it presses on them. If you have a prominence that has ever been red or callused at the end of a day, the upper on this shoe is the thing to be careful about, not the midsole.
The unanswered question is depth. The 928 has a reputation for taking an orthotic, and that reputation is probably deserved — but New Balance does not publish an internal depth, does not publish whether the insole is removable, and does not publish a stack height. “It has always worked for my patients” is a clinical impression, not a measurement, and this site was built specifically to stop treating the first as though it were the second. An Orthotic Volume Rating is what settles it.
A model that sits at v3 for years is telling you something useful. In footwear, frequent revisions usually serve marketing rather than feet, and every revision is a risk to the person who found a shoe that fits. A long-lived version is a genuine advantage for anyone who has to re-buy the same shoe every eight months — it is one of the few things in this market that behaves like a medical supply rather than a fashion item.
Who this shoe is probably for
Read from the published specification, not from wear. Treat these as hypotheses the test will confirm or overturn.
- Long shifts standing on hard floors — the whole specification points this way rather than at running.
- A foot that rolls in and needs a rearfoot post, in a shoe that looks like a work shoe rather than a trainer.
- You have found a shoe that works and need to re-buy it for years — the 928 has stayed at v3 for an unusually long time.
- A workplace that requires leather uppers — many healthcare and kitchen dress codes do.
- You have a bunion, hammertoe or bony prominence — leather presses on these where mesh gives, and no internal width is published.
- You need to know it will take your orthotic before you buy — the depth figure that would answer that does not exist yet.
- You want a light shoe — leather-uppered motion-control walkers are not light, and no shoe weight is published.
- You are running rather than walking in it — it is sold in the walking category and the cushioning is placed accordingly.
What changed from the previous version
There is no v4. New Balance’s 928 walking range currently lists the 928v3 as the shoe you can buy, at $159.99 and in stock, and the PAA box on Google’s own results page for this model asks whether it has been discontinued — the answer, as of 9 September 2026, is no.
New Balance publishes no changelog between the 928v2 and v3, and we will not invent one. If you are replacing an older 928 and something about the fit has changed on your feet, that is worth telling us about — corrections and reader reports are logged.
Other walking and standing-all-day reviews on this site: Brooks Addiction Walker 2, Vionic Walk Max and HOKA Transport 2.
Where to buy
Disclosure: the links below are paid links. If you buy through them Amazon pays us a commission at no cost to you. Commissions never influence a score, a ranking or the seal, and this page carries no score because the shoe has not been tested — see our independence policy.
Amazon listings are colourway-specific; the button opens one common colourway and you can switch colour and width there. List price $159.99 on September 9, 2026; prices move, check the listing.
Questions people ask about the 928v3
Is the New Balance 928v3 a good walking shoe?
For its actual job — hours upright on hard floors, on a foot that pronates, in a shoe that passes a leather dress code — it is one of the few current shoes built deliberately for that and not adapted to it. The caveats are honest ones: leather does not accommodate a bony prominence, and New Balance publishes no weight, no drop and no internal depth, so a lot of what you would want to know before spending $159.99 is simply not on the record. We have not tested this pair, so there is no score here.
Has the New Balance 928v3 been discontinued?
No. On 9 September 2026 the 928v3 was listed at $159.99 and in stock on newbalance.com in both men’s and women’s. The confusion is understandable — the 928 has stayed at v3 while most models cycle versions every year or two — but a long-lived version is a feature for anyone who has to re-buy the same shoe, not a sign that it is going away.
Which New Balance shoes do podiatrists recommend?
The model follows the foot, not the other way round. For a broad, overpronating foot that also needs depth, the 928 and the 1540 are the two that come up most; for ordinary stability the 860; for neutral cushioning the 880. What is actually being chosen in each case is width, depth, heel-counter stiffness and torsional rigidity — four properties almost nobody publishes, which is why we measure them.
What shoe is comparable to the New Balance 928?
The closest like-for-like is the Brooks Addiction Walker 2 — also a leather-uppered walking shoe with a rearfoot support device, aimed at the same shift-worker use. The New Balance 1540v4 is the more aggressive option if you need width beyond 4E. We say “comparable” rather than “equivalent” deliberately: until both are on the bench, nobody can tell you whether they hold an orthotic the same way.
What happens next
This model is in the queue for bench testing under Standard v1.0: weight on our scale at men’s US 10, heel and forefoot stack with calipers, internal toe-box width and depth, torsional rigidity, heel-counter stiffness and an Orthotic Volume Rating with a real orthotic inside it. If it goes on to wear testing, the nine-criterion scorecard and the seal decision follow. Every number will carry its own provenance label so you can see which figures we measured and which we are still quoting. If you own a pair and something on this page contradicts what is on your feet, tell us — corrections are logged.
Page type: spec analysis. Acquisition: not yet purchased. Last verified: September 9, 2026. Author: Tom Biernacki, DPM, FACFAS — board-certified foot and ankle surgeon, about.